Alaunos Therapeutics (TCRT) Current Leases (2019 - 2023)
Alaunos Therapeutics' (TCRT) quarterly Current Leases came in at $307000.0 in Q3 2023, down 43.36% YoY from $542000.0 in Q3 2022, and down 9.44% on a QoQ basis from $339000.0 in Q2 2023.
Alaunos Therapeutics (TCRT) Current Leases (2019 - 2023) Analysis & Trends
Alaunos Therapeutics (TCRT) has 5 years of Current Leases data on file, last reported at $307000.0 in Q3 2023.
- Quarterly Current Leases fell 43.36% year-over-year to $307000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $307000.0 (down 43.36% YoY) and the FY2022 annual result came in at $558000.0, down 23.46% from the prior year.
- Current Leases declined to $307000.0 in Q3 2023, from $339000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $866000.0 in Q3 2020 to a low of $307000.0 in Q3 2023.
- A 5-year average of $666315.8 and a median of $710000.0 in 2021 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2020 — Current Leases grew 28.57% — and 2023, when it tumbled 43.36%.
- Tracing TCRT's Current Leases over 5 years: stood at $774000.0 in 2019, then grew by 5.81% to $819000.0 in 2020, then retreated by 10.99% to $729000.0 in 2021, then slipped by 23.46% to $558000.0 in 2022, then plunged by 44.98% to $307000.0 in 2023.
- The last three Current Leases figures came in at $307000.0 (Q3 2023), $339000.0 (Q2 2023), and $575000.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 307,000.00 |
| Jun 30, 2023 | 339,000.00 |
| Mar 31, 2023 | 575,000.00 |
| Dec 31, 2022 | 558,000.00 |
| Sep 30, 2022 | 542,000.00 |
| Jun 30, 2022 | 525,000.00 |
| Mar 31, 2022 | 745,000.00 |
| Dec 31, 2021 | 729,000.00 |
| Sep 30, 2021 | 710,000.00 |
| Jun 30, 2021 | 765,000.00 |
| Mar 31, 2021 | 759,000.00 |
| Dec 31, 2020 | 819,000.00 |
| Sep 30, 2020 | 866,000.00 |
| Jun 30, 2020 | 838,000.00 |
| Mar 31, 2020 | 828,000.00 |
| Dec 31, 2019 | 774,000.00 |
| Sep 30, 2019 | 677,000.00 |
| Jun 30, 2019 | 660,000.00 |
| Mar 31, 2019 | 644,000.00 |